Sign in

You're signed outSign in or to get full access.

About Thomas J. Kenny

Independent Class I Board Member nominee (term to 2028) of Nuveen California AMT‑Free Quality Municipal Income Fund (NKX); first appointed to the NKX Board effective January 1, 2024, and has served within the Nuveen fund complex since 2011 . Year of birth: 1963; education: B.A. University of California, Santa Barbara; M.S. Golden Gate University; Chartered Financial Analyst (CFA) . Former Co‑Head of Global Cash and Fixed Income Portfolio Management at Goldman Sachs Asset Management; not an “interested person” under the Investment Company Act and deemed independent of TIAA/Nuveen .

Past Roles

OrganizationRoleTenureCommittees/Impact
Goldman Sachs Asset ManagementAdvisory Director; Partner; Managing Director; Co‑Head Global Cash & Fixed Income PM1999–2011 (MD 1999–2004; Partner 2004–2010; Advisory Director 2010–2011; Co‑Head 2002–2010)Led global cash/fixed income portfolio management
College Retirement Equities Fund (CREF)Trustee; Chairman2011–2023 (Chairman 2017–2023)Oversight of investment programs; governance leadership
TIAA Separate Account VA‑1Manager; Chairman2011–2023 (Chairman 2017–2023)Management committee leadership

External Roles

OrganizationRoleTenureCommittees/Impact
Aflac IncorporatedDirector; Chair, Finance & Investment CommitteeDirector since 2015; Chair since 2018Oversees finance/investment policies
ParentSquareDirector (former)2021–2022Board service at ed‑tech platform
Sansum ClinicDirector (former); Finance Committee Chair (former)Finance Chair 2016–2022; Director 2021–2022Financial oversight
B’BoxAdvisory Board Member (former)2017–2019Advisory role
UCSB Arts & Lectures Advisory CouncilMember (former)2011–2020Advancement and programming input
Cottage Health SystemInvestment Committee Member (former)2012–2020Investment oversight
Crane Country Day SchoolBoard Member; President of Board (former)2009–2019; President 2014–2018Governance leadership

Board Governance

  • Independence: Not an “interested person” of the Funds or of Nuveen/TIAA; never an employee or director of TIAA or Nuveen or affiliates, and thus an Independent Board Member .
  • Committee assignments: Executive Committee (Member); Dividend Committee (Member); Compliance, Risk Management & Regulatory Oversight Committee (Member); Nominating & Governance Committee (Member); Investment Committee (Member); Closed‑End Fund Committee (Member). Not listed on Audit Committee .
  • Attendance: Each Board Member, including Mr. Kenny, attended at least 75% of Board and committee meetings in the last fiscal year .
  • Board leadership: Independent Chair of the Board (Robert L. Young) with unitary board structure across the Nuveen fund complex .

NKX Board and Committee Workload (FY ended Aug 31, 2025)

Meeting TypeCount
Regular Board Meeting6
Special Board Meeting9
Executive Committee3
Dividend Committee8
Compliance, Risk Mgmt & Regulatory Oversight Committee4
Audit Committee13
Nominating & Governance Committee6
Investment Committee3
Closed‑End Funds Committee4

Fixed Compensation

  • Structure: Independent Board Member compensation is cash‑based retainers with committee fees; no director equity awards disclosed. Deferred compensation plan available at certain Nuveen funds; amounts track selected fund returns .
  • 2025 changes: Committee membership and chair fees increased effective January 1, 2025 .

Compensation Schedule (Pre‑2025 vs Effective 2025)

ComponentPre‑2025Effective 2025
Annual Board retainer (Independent)$350,000 $350,000
Audit Committee membership$30,000 $35,000
Compliance, Risk Mgmt & Regulatory Oversight membership$30,000 $35,000
Investment Committee membership$20,000 $30,000
Dividend, Nominating & Governance, Closed‑End membership$20,000 $25,000
Chair of the Board$140,000 $150,000
Audit & Compliance Committee Chair$30,000 $35,000
Investment Committee Chair/Co‑Chair$20,000 $30,000
Dividend, Nominating & Governance, Closed‑End Committee Chair$20,000 $25,000
Ad hoc meeting fees$1,000–$2,500 per meeting $1,000–$2,500 per meeting
Special assignment committee feesChair/co‑chair: from $1,250 quarterly; members: from $5,000 quarterly Chair/co‑chair: from $1,250 quarterly; members: from $5,000 quarterly

Last Fiscal Year Compensation (FY ended Aug 31, 2025)

ScopeAmount ($)
Total compensation from Nuveen funds (Mr. Kenny)$610,000
NKX (California AMT‑Free) – aggregate paid to Mr. Kenny$3,107

Deferred Compensation (booked to fund‑linked accounts)

FundDeferred Fees ($)
NKX (California AMT‑Free)707

Performance Compensation

  • No director stock awards, stock options, performance‑based bonuses, or equity‑linked director compensation disclosed; compensation described solely as retainers/fees with optional deferred compensation plan .

Other Directorships & Interlocks

Company/InstitutionTypeRoleTenureNotes
Aflac IncorporatedPublic companyDirector; Chair Finance & Investment CommitteeDirector since 2015; Chair since 2018Ongoing public board role; finance oversight
ParentSquarePrivateDirector (former)2021–2022Former directorship
CREF and TIAA VA‑1Investment entitiesTrustee/Manager; Chairman (former)2011–2023; Chair 2017–2023TIAA‑affiliated investment vehicles; past roles concluded 2023
  • Interlocks/affiliations: Past leadership roles at TIAA‑affiliated investment entities (CREF, VA‑1) could create perceived familiarity with Nuveen/TIAA; independence maintained under 1940 Act and listing standards .

Expertise & Qualifications

  • Fixed income and cash management expertise; senior leadership at GSAM including Co‑Head of Global Cash & Fixed Income PM .
  • Governance and finance experience across multiple boards; CFA designation; graduate education in finance .

Equity Ownership

  • Ownership policy: Nuveen funds boards expect each Board Member to invest at least the equivalent of one year of compensation in funds within the Fund Complex (direct or deferred) .
  • Beneficial ownership in NKX and related Nuveen closed‑end funds as of Oct 22, 2025:
    • NKX shares owned: 0; aggregate beneficial ownership across the Fund Complex: “Over $100,000” (range disclosure) .

Related‑Party Exposure (Holdings in companies advised by affiliates under common control with Adviser)

Owner/VehicleCompanyTitle of ClassValue ($)Percent of Class
Thomas Joseph Kenny 2021 TrustGlobal Timber Resources LLCNone34,0630.01%
KSHFO, LLC 4Global Timber Resources Investor Fund, LPNone523,0496.01%
KSHFO, LLC 4TIAA‑CREF Global Agriculture II LLCNone770,2000.05%
KSHFO, LLC 4Global Agriculture II AIV (US) LLCNone681,2370.17%
  • Mr. Kenny owns 6.60% of KSHFO, LLC .

Governance Assessment

  • Strengths:
    • Deep fixed‑income and portfolio management experience; long service in the Nuveen fund complex enhances oversight quality .
    • Robust committee engagement across Executive, Investment, Dividend, Compliance, Nominating, and Closed‑End committees; consistent attendance (≥75%) supports board effectiveness .
    • Clear independence under 1940 Act; independent Board Chair structure and comprehensive committee charters strengthen governance .
  • Alignment and incentives:
    • Policy expects one‑year compensation invested in Nuveen funds; Mr. Kenny’s aggregate range shows “Over $100,000,” but he held 0 shares in NKX specifically as of Oct 22, 2025, which may weaken fund‑specific alignment despite complex‑wide exposure; deferred fees recorded for NKX .
  • Potential conflicts and RED FLAGS:
    • Holdings in entities advised by affiliates under Nuveen/TIAA control (e.g., Global Timber Resources Investor Fund LP; TIAA‑CREF Global Agriculture II) create potential perceived related‑party exposure; transparency provided with detailed values/percentages .
    • Past leadership on TIAA‑affiliated CREF/VA‑1 may contribute to familiarity risks; independence designation mitigates regulatory concern, but investors should monitor for conflicts in valuation, leverage, and distribution oversight given committee roles .
  • Compensation structure signals:
    • 2025 increase in committee fees elevates cash compensation while maintaining pay‑for‑service model; absence of equity/option awards reduces misalignment risk but may limit direct price‑linked incentives at the fund level .